Details der Publikation

Medienart:	Klinische Studie

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	WHO International Clinical Trials Registry Platform - (2022) vom: 10. Jan. Zur Gesamtaufnahme - year:2022

Sprache:	Unbestimmt

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: Newly diagnosed malignant gliomas Phase: Phase 1/Phase 2 Recruitment Status: Recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 22-03-2019, Last updated: 2022-11-24

ICTRP ID:	JPRN-jRCTs061180085 UMIN000002419

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG004884752


LEADER	01000caa a22002652 4500
001	CTG004884752
003	DE-627
005	20230425174905.0
007	cr uuu---uuuuu
008	210507s2022 xx \|\|\|\|\|o 00\| \|\|und c
035			\|a (DE-627)CTG004884752
035			\|a (UBBS_Klinische_Studien_WHO)JPRN-jRCTs061180085
035			\|a (UBBS_Klinische_Studien_WHO)UMIN000002419
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a und
245	1	0	\|a W10TR-GBM2 \|b WT1 peptide immunotherapy in combination with surgery, irradiation, and temozolomide chemotherapy for malignant glioma: A phase I/II study. - W10TR-GBM2
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 22-03-2019, Last updated: 2022-11-24
650		4	\|a Medical Condition: Newly diagnosed malignant gliomas
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 1/Phase 2
650		4	\|a Recruitment Status: Recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2022) vom: 10. Jan.
773	1	8	\|g year:2022 \|g day:10 \|g month:01
856	4	0	\|u https://jrct.niph.go.jp/latest-detail/jRCTs061180085 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2022 \|b 10 \|c 01